Surgical Management and Outcomes of Renal Tumors Arising from Horseshoe Kidneys: Results from an International Multicenter Collaboration.


Journal

European urology
ISSN: 1873-7560
Titre abrégé: Eur Urol
Pays: Switzerland
ID NLM: 7512719

Informations de publication

Date de publication:
01 2021
Historique:
received: 10 07 2020
accepted: 03 09 2020
pubmed: 21 9 2020
medline: 28 9 2021
entrez: 20 9 2020
Statut: ppublish

Résumé

Despite being the most frequent renal fusion anomaly, tumors arising from horseshoe kidneys (HSKs) are extremely rare and management guidance is lacking. To evaluate the perioperative, oncological, and functional outcomes of surgically treated HSK tumors. A retrospective, multicenter cohort study of 43 HSK tumors in 40 patients was conducted, and technical description of the surgical approach has been provided. Surgical resection of renal tumors arising from HSKs was performed either via open surgery or via minimally invasive surgery (MIS). We analyzed patient and tumor characteristics as well as surgical technique, and functional and oncological outcomes. Eight patients were treated by MIS and 32 by open surgery. One patient (2.5%) experienced an intraoperative complication and 13 patients (32.5%) experienced postoperative complications, of which three (7.5%) were Clavien-Dindo ≥3 complications. Surgical margins were positive in two tumors (4.7%). The most frequent histology was clear-cell renal cell carcinoma (46.5%). The median follow-up was 51 (interquartile range [IQR] 17-73) mo. The 5-yr overall, cancer-specific, and recurrence-free survival rates were 81.2%, 86.8%, and 83.1%, respectively. The percent decreases in estimated glomerular filtration rate at discharge and the last follow-up were 15% (IQR 4-26%) and 17% (IQR 1-31%), respectively. Limitations include the cohort's retrospective nature, heterogeneity, and small sample size. Surgical management of tumors in HSKs can be approached via both open surgery and MIS, with maximal preservation of functional renal parenchyma. In this cohort, rates of complications, positive surgical margins, and renal functional decrease were acceptable, considering the anatomical complexity of these kidneys and tumors. These tumors display great variation in histological subtypes. Meticulous presurgical planning, taking advantage of advanced imaging techniques, can aid in achieving good outcomes. We evaluated the surgical management of renal tumors in horseshoe kidneys, which are very rare. Although these procedures are highly complex, outcomes are acceptable. Modern imaging techniques are often required in presurgical planning.

Sections du résumé

BACKGROUND
Despite being the most frequent renal fusion anomaly, tumors arising from horseshoe kidneys (HSKs) are extremely rare and management guidance is lacking.
OBJECTIVE
To evaluate the perioperative, oncological, and functional outcomes of surgically treated HSK tumors.
DESIGN, SETTING, AND PARTICIPANTS
A retrospective, multicenter cohort study of 43 HSK tumors in 40 patients was conducted, and technical description of the surgical approach has been provided.
SURGICAL PROCEDURE
Surgical resection of renal tumors arising from HSKs was performed either via open surgery or via minimally invasive surgery (MIS).
MEASUREMENTS
We analyzed patient and tumor characteristics as well as surgical technique, and functional and oncological outcomes.
RESULTS AND LIMITATIONS
Eight patients were treated by MIS and 32 by open surgery. One patient (2.5%) experienced an intraoperative complication and 13 patients (32.5%) experienced postoperative complications, of which three (7.5%) were Clavien-Dindo ≥3 complications. Surgical margins were positive in two tumors (4.7%). The most frequent histology was clear-cell renal cell carcinoma (46.5%). The median follow-up was 51 (interquartile range [IQR] 17-73) mo. The 5-yr overall, cancer-specific, and recurrence-free survival rates were 81.2%, 86.8%, and 83.1%, respectively. The percent decreases in estimated glomerular filtration rate at discharge and the last follow-up were 15% (IQR 4-26%) and 17% (IQR 1-31%), respectively. Limitations include the cohort's retrospective nature, heterogeneity, and small sample size.
CONCLUSIONS
Surgical management of tumors in HSKs can be approached via both open surgery and MIS, with maximal preservation of functional renal parenchyma. In this cohort, rates of complications, positive surgical margins, and renal functional decrease were acceptable, considering the anatomical complexity of these kidneys and tumors. These tumors display great variation in histological subtypes. Meticulous presurgical planning, taking advantage of advanced imaging techniques, can aid in achieving good outcomes.
PATIENT SUMMARY
We evaluated the surgical management of renal tumors in horseshoe kidneys, which are very rare. Although these procedures are highly complex, outcomes are acceptable. Modern imaging techniques are often required in presurgical planning.

Identifiants

pubmed: 32950296
pii: S0302-2838(20)30703-X
doi: 10.1016/j.eururo.2020.09.012
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

133-140

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Auteurs

Eduard Roussel (E)

Department of Urology, University Hospitals Leuven, Leuven, Belgium.

Giovanni Tasso (G)

Department of Urology, University of Florence, Careggi Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Riccardo Campi (R)

Department of Urology, University of Florence, Careggi Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Maximilian C Kriegmair (MC)

Department of Urology, University Medical Centre Mannheim, Mannheim, Germany.

Önder Kara (Ö)

Department of Urology, Kocaeli University School of Medicine, Kocaeli, Turkey.

Tobias Klatte (T)

Department of Urology, Royal Bournemouth Hospital, Bournemouth, UK; Department of Surgery, University of Cambridge, Cambridge, UK.

Umberto Capitanio (U)

Unit of Urology, University Vita-Salute, San Raffaele Scientific Institute, Milan, Italy; Division of Experimental Oncology, URI, Urological Research Institute, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Riccardo Bertolo (R)

Department of Urology, San Carlo di Nancy Hospital, Rome, Italy.

Alexandre Ingels (A)

Department of Urology, University Hospital Henri Mondor, APHP, UPEC, Créteil, France.

Selcuk Erdem (S)

Department of Urology, Istanbul University Istanbul Faculty of Medicine, Istanbul, Turkey.

Loïc Baekelandt (L)

Department of Urology, University Hospitals Leuven, Leuven, Belgium.

Maria C Mir (MC)

Department of Urology, Fundacion Instituto Valenciano Oncologia, Valencia, Spain.

Idir Ouzaid (I)

Department of Urology, Bichat Claude Bernard Hospital, Paris, France.

Nicola Pavan (N)

Urology Clinic, Department of Medical, Surgical and Health Science, University of Trieste, Trieste, Italy.

Benoit Beuselinck (B)

Department of Medical Oncology, University Hospitals Leuven, Leuven, Belgium.

Mauro Gacci (M)

Department of Urology, University of Florence, Careggi Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Andrea Minervini (A)

Department of Urology, University of Florence, Careggi Hospital, Florence, Italy; Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy.

Alessandro Volpe (A)

Department of Urology, University of Eastern Piedmont, Maggiore della Carità Hospital, Novara, Italy.

Maarten Albersen (M)

Department of Urology, University Hospitals Leuven, Leuven, Belgium. Electronic address: maarten.albersen@uzleuven.be.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH